NASDAQ:CAPR

Capricor Shares Fall, FDA Call in August Looms
····

Capricor Shares Fall, FDA Call in August Looms

Capricor Therapeutics shares fell 4.8% to $28.53 on Monday, bucking gains in major U.S. indexes. The company’s market value stands near $1.64 billion as investors await the FDA’s Aug. 22 decision on its experimental Duchenne muscular dystrophy therapy, deramiocel. Biotech stocks broadly declined, with the Nasdaq Biotechnology Index down 1.9%. Trading resumes Tuesday morning in New York.
June 2, 2026

Stock Market Today

  • International Stock Exchanges Urge Unified Green Finance Regulations
    June 2, 2026, 7:20 AM EDT. An international consortium of securities exchanges called on governments and regulators globally to address fragmented sustainability rules, aiming to streamline cross-border capital flows. The group highlighted the challenges investors face due to inconsistent environmental, social, and governance (ESG) standards, which impede efficient investment in green initiatives. They urged collaboration to harmonize regulations, facilitating the growth of sustainable finance and enabling a more coherent global market for green assets. This move seeks to boost transparency and investor confidence in the sustainable investment landscape amid increasing demand for green finance.